Upside | ||||||
---|---|---|---|---|---|---|
087010 | 3.49% | aa.aa | 207,000 | +1.72% | 30,745 | |
298380 | 3.34% | aa.aa | 66,000 | -0.45% | 73,745 | |
445680 | 3.19% | aa.aa | 38,900.00 | +7.16% | 189,415 | |
007390 | 3.18% | aa.aa | 29,400 | +2.98% | 174,795 | |
086900 | 2.66% | aa.aa | 165,400 | -1.49% | 21,930 | |
347850 | 2.52% | aa.aa | 125,400.00 | -1.26% | 53,750 | |
336570 | 2.37% | aa.aa | 10,850 | +1.88% | 414,090 | |
145720 | 2.27% | aa.aa | 64,200 | -1.08% | 44,720 | |
214450 | 2.20% | aa.aa | 499,500 | +3.95% | 8,385 | |
314930 | 2.11% | aa.aa | 15,490 | -4.91% | 204,895 |
KODEX Biotech is an exchange traded fund launched and managed by Samsung Asset Management Co. Ltd. It invests in the public equity of South Korea. The fund seeks to invest in the stocks of companies operating in the biotechnology sector. It invests in the stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the FnGuide Bio Index, by investing in the stocks of companies as per their weightings in the index. KODEX Biotech was formed on May 12, 2016 and is domiciled in South Korea.